down arrow

Metropolis Healt

  • Market Cap: Mid Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE112L01020
  • NSEID: METROPOLIS
  • BSEID: 542650
INR
1,577.70
4.2 (0.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 62.84 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,562.001,621.00

52 Week

1,383.702,306.85
Valuation
Technical
Day's Volume

CASH

62.84 k (31.54%) Volume

Shareholding (Dec 2024)

FII

16.73%

Held by 159 FIIs

DII

30.00%

Held by 35 DIIs

Promoter

49.40%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 9.12% and Operating profit at 0.90% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 12.5, it has a Expensive valuation with a 6.8 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 8,091 Cr (Mid Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

12.50%

stock-summary
Price to Book

6.82

Revenue and Profits (1 Year):
Net Sales:
323 Cr
(Quarterly Results - Dec 2024)
Net Profit:
31 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-30.28%
0%
-30.28%
1 Year
-12.32%
0%
-12.32%
2 Years
27.68%
0.30%
27.98%
3 Years
-35.99%
0.59%
-35.4%
4 Years
-36.47%
0.87%
-35.6%
5 Years
16.12%
2.19%
18.31%

Latest dividend: 4 per share ex-dividend date: Nov-17-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.12%
EBIT Growth (5y)
0.90%
EBIT to Interest (avg)
14.44
Debt to EBITDA (avg)
0.64
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.08
Tax Ratio
25.59%
Dividend Payout Ratio
16.03%
Pledged Shares
1.18%
Institutional Holding
46.73%
ROCE (avg)
35.60%
ROE (avg)
18.33%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
55
Price to Book Value
6.82
EV to EBIT
37.69
EV to EBITDA
25.18
EV to Capital Employed
6.79
EV to Sales
6.13
PEG Ratio
2.42
Dividend Yield
NA
ROCE (Latest)
17.64%
ROE (Latest)
12.50%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

1.1845

Mutual Funds

Held by 27 Schemes (26.37%)

FIIs

Held by 159 FIIs (16.73%)

Promoter with highest holding

Metz Advisory Llp (30.61%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Focused 30 Fund (9.71%)

Individual Investors Holdings

3.34%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -7.72% vs 11.63% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -32.59% vs 22.58% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "322.77",
          "val2": "349.79",
          "chgp": "-7.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "72.02",
          "val2": "89.88",
          "chgp": "-19.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.53",
          "val2": "4.79",
          "chgp": "-5.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.36",
          "val2": "46.52",
          "chgp": "-32.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.31%",
          "val2": "25.70%",
          "chgp": "-3.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 13.24% vs 0.93% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 31.47% vs -12.86% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "663.14",
          "val2": "585.59",
          "chgp": "13.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "168.69",
          "val2": "137.75",
          "chgp": "22.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.44",
          "val2": "11.66",
          "chgp": "-19.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "84.47",
          "val2": "64.25",
          "chgp": "31.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.44%",
          "val2": "23.52%",
          "chgp": "1.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 12.46% vs 1.28% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 26.71% vs -16.54% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "985.91",
          "val2": "876.71",
          "chgp": "12.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "240.71",
          "val2": "202.60",
          "chgp": "18.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.97",
          "val2": "16.97",
          "chgp": "-17.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "115.83",
          "val2": "91.41",
          "chgp": "26.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.42%",
          "val2": "23.11%",
          "chgp": "1.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.18% vs -6.52% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -10.54% vs -33.29% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,207.71",
          "val2": "1,148.21",
          "chgp": "5.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "282.58",
          "val2": "288.30",
          "chgp": "-1.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "22.54",
          "val2": "26.80",
          "chgp": "-15.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "127.82",
          "val2": "142.88",
          "chgp": "-10.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.40%",
          "val2": "25.11%",
          "chgp": "-1.71%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
322.77
349.79
-7.72%
Operating Profit (PBDIT) excl Other Income
72.02
89.88
-19.87%
Interest
4.53
4.79
-5.43%
Exceptional Items
0.00
0.00
Consolidate Net Profit
31.36
46.52
-32.59%
Operating Profit Margin (Excl OI)
22.31%
25.70%
-3.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -7.72% vs 11.63% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -32.59% vs 22.58% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
663.14
585.59
13.24%
Operating Profit (PBDIT) excl Other Income
168.69
137.75
22.46%
Interest
9.44
11.66
-19.04%
Exceptional Items
0.00
0.00
Consolidate Net Profit
84.47
64.25
31.47%
Operating Profit Margin (Excl OI)
25.44%
23.52%
1.92%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 13.24% vs 0.93% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 31.47% vs -12.86% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
985.91
876.71
12.46%
Operating Profit (PBDIT) excl Other Income
240.71
202.60
18.81%
Interest
13.97
16.97
-17.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
115.83
91.41
26.71%
Operating Profit Margin (Excl OI)
24.42%
23.11%
1.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 12.46% vs 1.28% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 26.71% vs -16.54% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,207.71
1,148.21
5.18%
Operating Profit (PBDIT) excl Other Income
282.58
288.30
-1.98%
Interest
22.54
26.80
-15.90%
Exceptional Items
0.00
0.00
Consolidate Net Profit
127.82
142.88
-10.54%
Operating Profit Margin (Excl OI)
23.40%
25.11%
-1.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 5.18% vs -6.52% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -10.54% vs -33.29% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Metropolis Healthcare Ltd stock-summary
stock-summary
Metropolis Healthcare Ltd
Mid Cap
Hospital & Healthcare Services
Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."